EP0179254B1 - Acides dihydro-4,5 oxo-4[(trans-phényl-2 cyclopropyl)amino]-2 furanecarboxyliques-3 et leurs dérivés - Google Patents
Acides dihydro-4,5 oxo-4[(trans-phényl-2 cyclopropyl)amino]-2 furanecarboxyliques-3 et leurs dérivés Download PDFInfo
- Publication number
- EP0179254B1 EP0179254B1 EP85111574A EP85111574A EP0179254B1 EP 0179254 B1 EP0179254 B1 EP 0179254B1 EP 85111574 A EP85111574 A EP 85111574A EP 85111574 A EP85111574 A EP 85111574A EP 0179254 B1 EP0179254 B1 EP 0179254B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- trans
- amino
- oxo
- dihydro
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 title claims abstract description 20
- 150000001875 compounds Chemical class 0.000 claims description 20
- 238000000034 method Methods 0.000 claims description 14
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims description 8
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 8
- 239000002253 acid Substances 0.000 claims description 7
- 150000002148 esters Chemical class 0.000 claims description 6
- 229910052783 alkali metal Inorganic materials 0.000 claims description 5
- 125000003545 alkoxy group Chemical group 0.000 claims description 4
- 125000004432 carbon atom Chemical group C* 0.000 claims description 4
- 239000012948 isocyanate Substances 0.000 claims description 3
- 150000002513 isocyanates Chemical class 0.000 claims description 3
- 229910000288 alkali metal carbonate Inorganic materials 0.000 claims description 2
- 150000008041 alkali metal carbonates Chemical class 0.000 claims description 2
- 238000005904 alkaline hydrolysis reaction Methods 0.000 claims description 2
- 238000007363 ring formation reaction Methods 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 3
- 239000002585 base Substances 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 claims 1
- -1 phenylcyclopropyl Chemical group 0.000 abstract description 5
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 230000000845 anti-microbial effect Effects 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 229910000029 sodium carbonate Inorganic materials 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- OHLRLMWUFVDREV-UHFFFAOYSA-N ethyl 4-chloro-3-oxobutanoate Chemical compound CCOC(=O)CC(=O)CCl OHLRLMWUFVDREV-UHFFFAOYSA-N 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 0 CC(OCC1*)=C1C(*)=O Chemical compound CC(OCC1*)=C1C(*)=O 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 238000002814 agar dilution Methods 0.000 description 2
- 238000002815 broth microdilution Methods 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- UCTNTYHJFWMUBD-UHFFFAOYSA-N 4-chloro-3-oxobutanoic acid Chemical compound OC(=O)CC(=O)CCl UCTNTYHJFWMUBD-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 125000005233 alkylalcohol group Chemical group 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229940125904 compound 1 Drugs 0.000 description 1
- 229940125782 compound 2 Drugs 0.000 description 1
- 229940126214 compound 3 Drugs 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- SRCZQMGIVIYBBJ-UHFFFAOYSA-N ethoxyethane;ethyl acetate Chemical compound CCOCC.CCOC(C)=O SRCZQMGIVIYBBJ-UHFFFAOYSA-N 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 239000012065 filter cake Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- DBBRJAWSDTYYBM-UHFFFAOYSA-N isocyanatocyclopropane Chemical compound O=C=NC1CC1 DBBRJAWSDTYYBM-UHFFFAOYSA-N 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 150000004682 monohydrates Chemical class 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Definitions
- This invention relates generally to 2-[(N-substituted)amino]-4,5-dihydro-4-oxo-3-furancarboxylic acids and more specifically to 4,5-dihydro-4-oxo-2-[(2-trans-phenylcyclopropyl)amino]-3-furancarbox- ylic acids and derivatives thereof.
- the compounds of the invention are carboxylic acids and acid derivatives including alkali metal salts of the acid, esters formed from lower alkyl alcohols.
- R 1 in the general formula include phenyl and substituted phenyl wherein the term "substituted phenyl” as used herein refers to phenyl substituted with lower alkyl and/or halogen (chlorine, fluorine, bromine, iodine), preferably chlorine.
- the compounds of the invention can be prepared as illustrated in the following diagram which involves a base-catalyzed cyclocondensation of C 1 ⁇ C 8 4-chloroacetoacetate I with an appropriate trans-phenylcyclopropyl isocyanate 11 to provide the esters lll.
- Alkaline hydrolysis of esters III gives the corresponding free acids IV.
- treatment of the free acids IV with sodium carbonate (or another alkali metal carbonate) gives the salts VII.
- Compound 2 was prepared by a similar process to that described in Example 1 with trans-4-chlorophe- nylcyclopropylisocyanate being reacted with ethyl 4-chloroacetoacetate.
- Compound 3 was prepared by a similar process to that described in Example 1 with trans-4-(methylphenyl)cyclopropylisocyanate being reacted with ethyl 4-chloroacetoacetate.
- the compound 4 (5.05 grams, 19.5 mmol), was neutralized with sodium carbonate (2.56 grams, 24.2 mmol) in 150 ml water. The solution was warmed to 50 ° C, then filtered and concentrated to 50 ml under vacuum. The addition of a small amount of ethanol caused a rapid crystallization of the sodium salt 7. Recrystallization from water provided 4.66 grams of pure sodium salt as the monohydrate.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Claims (11)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT85111574T ATE41773T1 (de) | 1984-09-24 | 1985-09-13 | 4,5-dihydro-4-oxo-2((2-transphenylcyclopropyl)amino>-3-furancarbonsaeuren und derivate davon. |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US653254 | 1984-09-24 | ||
| US06/653,254 US4614810A (en) | 1984-09-24 | 1984-09-24 | 4,5-dihydro-4-oxo-2-[(2-trans-phenylcyclopropyl)amino]-3-furancarboxylic acids and derivatives thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP0179254A1 EP0179254A1 (fr) | 1986-04-30 |
| EP0179254B1 true EP0179254B1 (fr) | 1989-03-29 |
Family
ID=24620098
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP85111574A Expired EP0179254B1 (fr) | 1984-09-24 | 1985-09-13 | Acides dihydro-4,5 oxo-4[(trans-phényl-2 cyclopropyl)amino]-2 furanecarboxyliques-3 et leurs dérivés |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US4614810A (fr) |
| EP (1) | EP0179254B1 (fr) |
| JP (1) | JPS6178778A (fr) |
| KR (1) | KR860002489A (fr) |
| AT (1) | ATE41773T1 (fr) |
| AU (1) | AU570572B2 (fr) |
| CA (1) | CA1240687A (fr) |
| DE (1) | DE3569112D1 (fr) |
| DK (1) | DK429585A (fr) |
| FI (1) | FI853648A7 (fr) |
| IL (1) | IL76194A (fr) |
| NO (1) | NO853737L (fr) |
| NZ (1) | NZ213190A (fr) |
| PH (1) | PH21253A (fr) |
| ZA (1) | ZA856907B (fr) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA912138B (en) * | 1990-03-26 | 1991-12-24 | Schering Corp | Bcrf1 antagonists for treating epstein-barr virus infections |
| US7186735B2 (en) * | 2002-08-07 | 2007-03-06 | Sanofi-Aventis Deutschland Gmbh | Acylated arylcycloalkylamines and their use as pharmaceuticals |
| EP1388535A1 (fr) * | 2002-08-07 | 2004-02-11 | Aventis Pharma Deutschland GmbH | Arylcycloalkylamines acylés et leurs utilisations comme produits pharmaceutiques |
| EP3105219B9 (fr) | 2014-02-13 | 2018-10-03 | Incyte Corporation | Cyclopropylamines en tant qu'inhibiteurs de lsd1 |
| US9527835B2 (en) | 2014-02-13 | 2016-12-27 | Incyte Corporation | Cyclopropylamines as LSD1 inhibitors |
| SI3105218T1 (sl) * | 2014-02-13 | 2019-11-29 | Incyte Corp | Ciklopropilamini kot inhibitorji LSD1 |
| MX373103B (es) | 2014-02-13 | 2020-04-17 | Incyte Holdings Corp | Ciclopropilaminas como inhibidores de desmetilasa específica de lisina 1 (lsd1). |
| TWI687419B (zh) | 2014-07-10 | 2020-03-11 | 美商英塞特公司 | 作為lsd1抑制劑之咪唑并吡啶及咪唑并吡嗪 |
| TW201613925A (en) | 2014-07-10 | 2016-04-16 | Incyte Corp | Imidazopyrazines as LSD1 inhibitors |
| WO2016007722A1 (fr) | 2014-07-10 | 2016-01-14 | Incyte Corporation | Triazolopyridines et triazolopyrazines utilisables comme inhibiteurs de lsd1 |
| EP3277689B1 (fr) | 2015-04-03 | 2019-09-04 | Incyte Corporation | Composés hétérocycliques utilisés en tant qu'inhibiteurs de lsd1 |
| LT3334709T (lt) | 2015-08-12 | 2025-03-10 | Incyte Holdings Corporation | Lsd1 inhibitoriaus druskos |
| WO2020047198A1 (fr) | 2018-08-31 | 2020-03-05 | Incyte Corporation | Sels d'un inhibiteur de lsd1 et leurs procédés de préparation |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1210848A (en) * | 1968-07-01 | 1970-11-04 | Mcneilab Inc | 2-imino-methyleneimines |
| US4244958A (en) * | 1979-05-10 | 1981-01-13 | American Home Products Corporation | Hypolipidemic derivatives of 4,5-dihydro-4-oxofuran-2-carboxylic acid |
| DE3301107A1 (de) * | 1983-01-14 | 1984-07-19 | Ozaki, Shoichiro, Ehime | Neue 1-(n-substituierte carbamoyl)-5-fluorouracil-derivate und krebshemmende mittel, in denen sie als aktive bestandteile enthalten sind |
-
1984
- 1984-09-24 US US06/653,254 patent/US4614810A/en not_active Expired - Fee Related
-
1985
- 1985-08-14 CA CA000488712A patent/CA1240687A/fr not_active Expired
- 1985-08-19 AU AU46298/85A patent/AU570572B2/en not_active Ceased
- 1985-08-21 NZ NZ213190A patent/NZ213190A/en unknown
- 1985-08-23 PH PH32682A patent/PH21253A/en unknown
- 1985-08-26 IL IL76194A patent/IL76194A/xx unknown
- 1985-09-10 ZA ZA856907A patent/ZA856907B/xx unknown
- 1985-09-13 EP EP85111574A patent/EP0179254B1/fr not_active Expired
- 1985-09-13 AT AT85111574T patent/ATE41773T1/de active
- 1985-09-13 DE DE8585111574T patent/DE3569112D1/de not_active Expired
- 1985-09-17 JP JP60203591A patent/JPS6178778A/ja active Pending
- 1985-09-23 NO NO853737A patent/NO853737L/no unknown
- 1985-09-23 FI FI853648A patent/FI853648A7/fi not_active Application Discontinuation
- 1985-09-23 DK DK429585A patent/DK429585A/da not_active Application Discontinuation
- 1985-09-24 KR KR1019850006996A patent/KR860002489A/ko not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| DE3569112D1 (en) | 1989-05-03 |
| FI853648L (fi) | 1986-03-25 |
| FI853648A7 (fi) | 1986-03-25 |
| US4614810A (en) | 1986-09-30 |
| EP0179254A1 (fr) | 1986-04-30 |
| NO853737L (no) | 1986-03-25 |
| FI853648A0 (fi) | 1985-09-23 |
| ATE41773T1 (de) | 1989-04-15 |
| DK429585A (da) | 1986-03-25 |
| AU570572B2 (en) | 1988-03-17 |
| JPS6178778A (ja) | 1986-04-22 |
| DK429585D0 (da) | 1985-09-23 |
| NZ213190A (en) | 1988-04-29 |
| IL76194A (en) | 1988-06-30 |
| AU4629885A (en) | 1986-04-10 |
| CA1240687A (fr) | 1988-08-16 |
| PH21253A (en) | 1987-08-31 |
| ZA856907B (en) | 1987-03-25 |
| IL76194A0 (en) | 1985-12-31 |
| KR860002489A (ko) | 1986-04-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4794185A (en) | Process for the preparation of imidazopyridines | |
| EP0179254B1 (fr) | Acides dihydro-4,5 oxo-4[(trans-phényl-2 cyclopropyl)amino]-2 furanecarboxyliques-3 et leurs dérivés | |
| US5728841A (en) | Process for preparing 1-amino-1,2,3-triazole | |
| US4826989A (en) | Process for the preparation of luciferin compounds | |
| US4390723A (en) | Process for producing hydroxyphenyl aliphatic acid derivatives | |
| US4670191A (en) | Process for the preparation of N-phosphonomethylglycine | |
| KR960008664B1 (ko) | 2,6-디클로로디페닐아미노아세트산 유도체류의 제조공정 | |
| US2541924A (en) | Synthesis of substituted imidazoles | |
| US6239277B1 (en) | Process for preparing piperazine-substituted aliphatic carboxylates | |
| US4567261A (en) | Preparation of riboflavin | |
| US4273932A (en) | 4-Hydroxy-5,6,7,8-tetrahydroquinoline-3-carboxylic acids and derivatives | |
| US4292431A (en) | Process for the production of hydroxymethylimidazoles | |
| US4709044A (en) | Biotin intermediates | |
| US4017512A (en) | Process for producing N-alkylhydroxylamines | |
| US4009172A (en) | 2,3,3A,6,7,7A-Hexahydro-thieno[3,2-b]pyridin-(4H)5-ones | |
| US4118501A (en) | Thiazolidine derivatives | |
| US4459239A (en) | Chloroformates of alkyl esters of C-alkyl- or C-haloalkyl tartronic acids and process for their preparation | |
| US4780542A (en) | Process for the synthesis of esters and amides of carboxylic acids | |
| US5081277A (en) | Process for the preparation of propionic acid derivatives | |
| SU816400A3 (ru) | Способ получени производныхТиАзОлидиНКАРбОНОВыХ КиСлОТ | |
| SU1447823A1 (ru) | Соли аналогов 7-оксо-PGJ @ с эфедрином,про вл ющие тормоз щее свертываемость крови действие и снижающие кров ное давление | |
| US4782165A (en) | Process for biotin intermediates | |
| US4130559A (en) | Method for the preparation of 6-aminopenicillinic acid derivatives | |
| US4476306A (en) | Method of preparing 2,4-dihydroxypyrimidine | |
| US4156735A (en) | Thiazolidine derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE FR GB IT LI LU NL SE |
|
| 17P | Request for examination filed |
Effective date: 19860903 |
|
| 17Q | First examination report despatched |
Effective date: 19871116 |
|
| GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
| ITF | It: translation for a ep patent filed | ||
| AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE CH DE FR GB IT LI LU NL SE |
|
| REF | Corresponds to: |
Ref document number: 41773 Country of ref document: AT Date of ref document: 19890415 Kind code of ref document: T |
|
| REF | Corresponds to: |
Ref document number: 3569112 Country of ref document: DE Date of ref document: 19890503 |
|
| ET | Fr: translation filed | ||
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Effective date: 19890913 Ref country code: AT Effective date: 19890913 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Effective date: 19890914 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19890930 Ref country code: LI Effective date: 19890930 Ref country code: CH Effective date: 19890930 Ref country code: BE Effective date: 19890930 |
|
| PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
| BERE | Be: lapsed |
Owner name: PENNWALT CORP. Effective date: 19890930 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Effective date: 19900401 |
|
| 26N | No opposition filed | ||
| GBPC | Gb: european patent ceased through non-payment of renewal fee | ||
| NLV4 | Nl: lapsed or anulled due to non-payment of the annual fee | ||
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Effective date: 19900531 |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DE Effective date: 19900601 |
|
| REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST |
|
| EUG | Se: european patent has lapsed |
Ref document number: 85111574.1 Effective date: 19900521 |

